7 independently checked trend briefs about this subject, newest first.
headlinez.news detected 7 source-qualified news clusters connected to Immunology between June 23, 2026 and July 27, 2026. They span 2 newsroom categories and average 7.0 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
A $2.2 billion acquisition agreement marks a significant shift in the immunology market, as Argenx moves to absorb Forte Biosciences.
New research identifies a breakdown in immune cell interactions as a primary factor in the biological aging process.
Researchers have identified the biological mechanism connecting Epstein-Barr virus infections to the development of multiple sclerosis.
Emerging research indicates that ovaries may function beyond reproduction, potentially adopting an immune role following menopause.
New research identifies a sex-specific GABA signaling pathway that facilitates glioblastoma progression in females.
AbbVie’s $10.9B bid for Apogee Therapeutics signals a high-stakes bet on next-gen autoimmune treatments—including a potential Dupixent rival.
AbbVie’s $10.9B bid for Apogee Therapeutics reshapes biotech M&A landscape overnight